 |
|
|
| |
A Baseline Predictive Tool for Selecting HBeAg-Negative Chronic Hepatitis B Patients Who Have a High Probability of Achieving Sustained Immune Control with Peginterferon Alfa-2a
|
| |
| |
Reported by Jules Levin
AASLD 2014 Nov 7-11 Boston
P. Lampertico1, V. Rothe2, A. Caputo3, G.V. Papatheodoridis4
1AM & A Migliavacca Center for Liver Disease, 1st Gastroenterology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy;
2IST GmbH, Mannheim, Germany; 3Roche S.p.A., Monza, Italy; 4Department of Gastroenterology, Athens University Medical School, Laiko General Hospital, Athens, Greece
|
| |
|
|
|
|
|
